Limited coverage drugs – pramipexole

Last updated on September 26, 2024

Generic name

pramipexole

Strength

0.25 mg, 1.0 mg, 1.5 mg 

Form

tablet

Special Authority criteria

Approval period

For the treatment of idiopathic Parkinson's disease, when

  • the patient is receiving treatment with levodopa and requires additional adjunctive therapy
    OR
  • the patient cannot tolerate or has contraindications to levodopa

Indefinite

Practitioner exemptions

  • None

Special notes

  • Pramipexole for restless leg syndrome is not eligible for PharmaCare coverage
  • Pramipexole 0.5 mg tablet is not a PharmaCare benefit

Special Authority requests